- Home
- AEI vs IBIO Comparison
AEI vs IBIO Comparison
Compare AEI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- IBIO
- Stock Information
- Founded
- AEI 2014
- IBIO 2008
- Country
- AEI United States
- IBIO United States
- Employees
- AEI N/A
- IBIO N/A
- Industry
- AEI Building operators
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- AEI Real Estate
- IBIO Health Care
- Exchange
- AEI Nasdaq
- IBIO Nasdaq
- Market Cap
- AEI 10.7M
- IBIO 9.3M
- IPO Year
- AEI N/A
- IBIO N/A
- Fundamental
- Price
- AEI $0.84
- IBIO $0.77
- Analyst Decision
- AEI
- IBIO Strong Buy
- Analyst Count
- AEI 0
- IBIO 3
- Target Price
- AEI N/A
- IBIO $4.87
- AVG Volume (30 Days)
- AEI 94.6K
- IBIO 776.1K
- Earning Date
- AEI 05-15-2025
- IBIO 05-02-2025
- Dividend Yield
- AEI N/A
- IBIO N/A
- EPS Growth
- AEI N/A
- IBIO N/A
- EPS
- AEI N/A
- IBIO N/A
- Revenue
- AEI $16,097,995.00
- IBIO $375,000.00
- Revenue This Year
- AEI N/A
- IBIO $36.00
- Revenue Next Year
- AEI N/A
- IBIO N/A
- P/E Ratio
- AEI N/A
- IBIO N/A
- Revenue Growth
- AEI N/A
- IBIO 650.00
- 52 Week Low
- AEI $0.70
- IBIO $0.64
- 52 Week High
- AEI $2.61
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- AEI 37.30
- IBIO 30.08
- Support Level
- AEI $0.77
- IBIO $0.70
- Resistance Level
- AEI $0.85
- IBIO $0.83
- Average True Range (ATR)
- AEI 0.06
- IBIO 0.06
- MACD
- AEI -0.02
- IBIO 0.08
- Stochastic Oscillator
- AEI 30.47
- IBIO 41.18
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.